# A Pilot Study of Metformin Treatment in Patients With Well-differentiated Neuroendocrine Tumors

> **NCT02279758** · PHASE2 · UNKNOWN · sponsor: **Instituto do Cancer do Estado de São Paulo** · enrollment: 30 (estimated)

## Conditions studied

- Well-differentiated Neuroendocrine Tumors

## Interventions

- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT02279758
- **Lead sponsor:** Instituto do Cancer do Estado de São Paulo
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2017-12
- **Final completion:** —
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02279758

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02279758, "A Pilot Study of Metformin Treatment in Patients With Well-differentiated Neuroendocrine Tumors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02279758. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*